Browse all treatments

alectinib

ALK-positive non-small cell lung cancer

brigatinib

ALK-positive metastatic NSCLC

bevacizumab

Anti-VEGF therapy used in selected colorectal, lung, kidney, cervical, ovarian/glioblastoma contexts

avelumab

Maintenance treatment in selected urothelial carcinoma and other contexts

encorafenib

BRAF inhibitor used in selected BRAF V600E colorectal cancer with cetuximab and melanoma contexts

encorafenib/binimetinib

BRAF/MEK targeted therapy for selected melanoma and other contexts

cabozantinib

TKI for renal cell carcinoma, hepatocellular carcinoma, thyroid cancer contexts

acalabrutinib

BTK inhibitor for selected blood cancers

ciltacabtagene autoleucel

BCMA-directed CAR-T therapy for multiple myeloma

daratumumab and hyaluronidase-fihj

Multiple myeloma and selected plasma-cell disorders

mirvetuximab soravtansine-gynx

Folate receptor alpha-directed ADC for selected ovarian cancer settings

fam-trastuzumab deruxtecan-nxki

HER2-directed antibody-drug conjugate for selected breast and other HER2-expressing cancers

cetuximab

EGFR inhibitor for selected colorectal and head/neck cancers

apalutamide

Androgen receptor inhibitor for prostate cancer

mobocertinib

EGFR exon 20 insertion NSCLC; confirm market status before use

palbociclib

CDK4/6 inhibitor for selected HR+/HER2- metastatic breast cancer settings

ibrutinib

BTK inhibitor for selected blood cancers

durvalumab

Immunotherapy used across selected lung, biliary tract, liver, bladder and other contexts

axitinib

Tyrosine kinase inhibitor for advanced renal cell carcinoma

ado-trastuzumab emtansine

HER2-directed ADC for selected HER2+ breast cancer settings

pembrolizumab

Immunotherapy used across multiple cancers including lung, melanoma, bladder, head and neck, colorectal MSI-H/dMMR and others

ribociclib

CDK4/6 inhibitor for selected HR+/HER2- breast cancer settings

adagrasib

KRAS G12C-mutated NSCLC and selected colorectal cancer contexts

tisagenlecleucel

CAR-T therapy for selected blood cancers

lenvatinib

TKI used in selected liver, kidney, thyroid, and endometrial cancer contexts

trifluridine/tipiracil

Oral chemotherapy for selected metastatic colorectal cancer and gastric cancer settings

lorlatinib

ALK-positive non-small cell lung cancer

sotorasib

KRAS G12C-mutated NSCLC and selected colorectal cancer contexts

olaparib

PARP inhibitor for selected BRCA-mutated breast and other cancers

darolutamide

Androgen receptor inhibitor for prostate cancer

irinotecan liposome injection

Treatment in selected pancreatic cancer settings

nivolumab

Immunotherapy used across multiple cancers including lung, melanoma, kidney, bladder, esophageal and others

enfortumab vedotin-ejfv

Nectin-4 ADC for selected urothelial cancer contexts

pertuzumab

HER2-targeted therapy for selected HER2+ breast cancer settings

lutetium Lu 177 vipivotide tetraxetan

Radioligand therapy for PSMA-positive metastatic castration-resistant prostate cancer

pomalidomide

Multiple myeloma and selected hematologic malignancy contexts

lenalidomide

Multiple myeloma and selected hematologic malignancies

amivantamab-vmjw

EGFR exon 20 insertion and other EGFR-mutated NSCLC settings

regorafenib

Multikinase inhibitor for selected colorectal, GIST, and liver cancer contexts

capmatinib

METex14-altered metastatic non-small cell lung cancer

dabrafenib/trametinib

BRAF/MEK targeted therapy for selected melanoma, NSCLC, thyroid and other contexts

osimertinib

EGFR-mutated non-small cell lung cancer

atezolizumab

Immunotherapy used across selected lung, liver, melanoma and other cancer contexts

sacituzumab govitecan-hziy

TROP-2 antibody-drug conjugate for selected breast cancer settings

panitumumab

EGFR inhibitor for selected RAS wild-type metastatic colorectal cancer

venetoclax

BCL-2 inhibitor for selected CLL/SLL and AML contexts

abemaciclib

CDK4/6 inhibitor for selected HR+/HER2- breast cancer settings

crizotinib

ALK or ROS1-positive metastatic NSCLC and selected other indications

enzalutamide

Androgen receptor inhibitor for prostate cancer

ipilimumab

CTLA-4 immunotherapy commonly used in combination with nivolumab in selected cancers

axicabtagene ciloleucel

CAR-T therapy for selected lymphomas

niraparib

PARP inhibitor for selected ovarian cancer settings

abiraterone acetate

Androgen biosynthesis inhibitor for prostate cancer

ticagrelor

Antiplatelet therapy after ACS / selected cardiovascular risk contexts

mavacamten

Obstructive hypertrophic cardiomyopathy

ivabradine

Heart failure / heart rate reduction

apixaban

Anticoagulant for AFib and VTE

sacubitril/valsartan

Heart failure

inclisiran

LDL-C lowering

pitavastatin

Cholesterol lowering

aspirin 81 mg

Antiplatelet therapy in selected patients; not casual primary prevention

bempedoic acid

LDL-C lowering

bempedoic acid/ezetimibe

LDL-C lowering

nicotine patch

Smoking cessation support

nicotine gum/lozenge

Smoking cessation support that can reduce cardiovascular risk

macitentan

Pulmonary arterial hypertension

alirocumab

LDL-C lowering

evolocumab

LDL-C lowering and ASCVD risk

edoxaban

Anticoagulant

acetaminophen

Pain/fever option often used when avoiding NSAIDs

icosapent ethyl

Triglycerides and cardiovascular risk reduction in selected patients

vericiguat

Heart failure

tafamidis

ATTR cardiomyopathy

sotatercept-csrk

Pulmonary arterial hypertension

rivaroxaban

Anticoagulant for AFib and VTE

insulin glargine biosimilar/follow-on

Basal insulin

glucose tablets/gel/liquid

Fast-acting carbohydrate for low blood sugar

dapagliflozin

Type 2 diabetes, heart failure, CKD

faster insulin aspart

Fast-acting insulin

glucose gel

Fast-acting carbohydrate for low blood sugar

insulin lispro

Mealtime insulin

canagliflozin

Type 2 diabetes / SGLT2 inhibitor

sitagliptin/metformin

Type 2 diabetes

sitagliptin

Type 2 diabetes

empagliflozin

Type 2 diabetes, heart failure, CKD

insulin glargine

Basal insulin

insulin lispro-aabc

Rapid-acting insulin

tirzepatide

Type 2 diabetes

insulin aspart

Mealtime insulin

regular insulin / NPH insulin

Insulin access in some settings

semaglutide

Type 2 diabetes with CV/kidney risk messaging for selected patients

glucose tablets

Fast-acting carbohydrate for low blood sugar

semaglutide oral

Type 2 diabetes

insulin glargine/lixisenatide

Basal insulin plus GLP-1 RA

insulin glargine U-300

Basal insulin

insulin degludec

Basal insulin

glucose tablets/gel

Fast-acting carbohydrate for low blood sugar

dulaglutide

Type 2 diabetes

liraglutide

Type 2 diabetes

insulin degludec/liraglutide

Basal insulin plus GLP-1 RA

fexofenadine

Allergy relief without decongestant when using non-D version

ramipril

ACE inhibitor for hypertension and cardiovascular risk contexts

saline nasal spray

Non-drug congestion support

candesartan

ARB for hypertension

irbesartan

ARB for hypertension

amlodipine/olmesartan

ARB plus CCB for hypertension

olmesartan

ARB for hypertension

nebivolol

Beta blocker for hypertension

loratadine

Allergy relief without decongestant when using non-D version

carvedilol ER

Beta blocker for cardiovascular use

varies by product

Cold/cough products marketed for people with high blood pressure

losartan

ARB for hypertension

valsartan

ARB for hypertension

azilsartan medoxomil

ARB for hypertension

azilsartan/chlorthalidone

ARB plus diuretic for hypertension

amlodipine/valsartan

ARB plus CCB for hypertension

ibuprofen

NSAID pain reliever that may raise blood pressure in some users

amlodipine oral suspension

Pediatric and adult hypertension option where liquid formulation is useful

amlodipine/benazepril

ACE inhibitor plus CCB for hypertension

telmisartan

ARB for hypertension

guaifenesin

Expectorant for chest congestion

naproxen

NSAID pain reliever that may raise blood pressure in some users

amlodipine

Calcium channel blocker for hypertension

pseudoephedrine

Decongestant that can raise blood pressure

dextromethorphan/guaifenesin

Cough suppressant/expectorant

aliskiren

Renin inhibitor for hypertension

metoprolol succinate

Beta blocker for hypertension and cardiovascular use

olmesartan/amlodipine/hydrochlorothiazide

Triple-combination hypertension therapy

lisinopril

ACE inhibitor for hypertension

cetirizine

Allergy relief without decongestant when using non-D version

aripiprazole LAI

Long-acting injectable for schizophrenia and bipolar I maintenance

mixed amphetamine salts ER

ADHD

aripiprazole lauroxil

Long-acting injectable for schizophrenia

dextromethorphan/bupropion

Major depressive disorder

serdexmethylphenidate/dexmethylphenidate

ADHD

lumateperone

MDD adjunct, bipolar depression, schizophrenia

iloperidone

Schizophrenia / bipolar I manic or mixed episodes depending on current labeling

paliperidone palmitate

Long-acting injectable for schizophrenia/schizoaffective disorder

methylphenidate HCl ER

ADHD

lurasidone

Bipolar depression and schizophrenia

olanzapine/samidorphan

Schizophrenia and bipolar I disorder

mixed amphetamine salts ER

ADHD

melatonin

Sleep support supplement

melatonin

Sleep support supplement

risperidone extended-release injectable

Schizophrenia

viloxazine ER

ADHD

brexpiprazole

MDD adjunct, schizophrenia, agitation associated with dementia due to Alzheimer’s disease

S-adenosyl-L-methionine

Complementary product sometimes used for mood symptoms

esketamine

Treatment-resistant depression / selected MDD crisis contexts

hypericum perforatum

Complementary product sometimes used for mood symptoms

vortioxetine

Major depressive disorder

doxylamine

Short-term nighttime sleep aid

risperidone extended-release injectable

Schizophrenia

cariprazine

MDD adjunct, bipolar I disorder, schizophrenia

lisdexamfetamine

ADHD and binge eating disorder

diphenhydramine

Short-term nighttime sleep aid

phentermine

Short-term weight management

orlistat 60 mg

OTC weight-loss aid

naltrexone/bupropion ER

Chronic weight management

setmelanotide

Rare genetic obesity disorders

phentermine

Short-term weight management

phentermine/topiramate ER

Chronic weight management

liraglutide 3 mg

Chronic weight management

semaglutide 2.4 mg

Chronic weight management and cardiovascular risk reduction in selected adults

orlistat 120 mg

Prescription weight management

tirzepatide

Chronic weight management and obesity-related obstructive sleep apnea in selected adults